Transforming drug development with synthetic biology and AI
Andrew B. Hill, Jane M. True, Charles H. Jones · Trends in biotechnology · 2024
The COVID-19 pandemic has thrust RNA as a platform for drug development into the spotlight. However, identifying promising drug candidates is challenging. With advances in synthetic biology and artificial intelligence (AI) models, we can overcome this hurdle, transforming drug development and ushering in a new era in the pharmaceutical industry.